These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 23555257)
1. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies. Sourisseau M; Michta ML; Zony C; Israelow B; Hopcraft SE; Narbus CM; Parra Martín A; Evans MJ PLoS Pathog; 2013 Mar; 9(3):e1003244. PubMed ID: 23555257 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model. Shimizu Y; Shirasago Y; Kondoh M; Suzuki T; Wakita T; Hanada K; Yagi K; Fukasawa M J Virol; 2018 Apr; 92(8):. PubMed ID: 29437969 [TBL] [Abstract][Full Text] [Related]
3. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo. Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007 [TBL] [Abstract][Full Text] [Related]
4. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma. Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454 [TBL] [Abstract][Full Text] [Related]
5. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process. Baktash Y; Madhav A; Coller KE; Randall G Cell Host Microbe; 2018 Mar; 23(3):382-394.e5. PubMed ID: 29544098 [TBL] [Abstract][Full Text] [Related]
6. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Ploss A; Evans MJ; Gaysinskaya VA; Panis M; You H; de Jong YP; Rice CM Nature; 2009 Feb; 457(7231):882-6. PubMed ID: 19182773 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection and tight junction proteins: The ties that bind. Mailly L; Baumert TF Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183296. PubMed ID: 32268133 [TBL] [Abstract][Full Text] [Related]
8. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins. Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus Disrupts Annexin 5-Mediated Occludin Integrity through Downregulation of Protein Kinase Cα (PKCα) and PKCη Expression, Thereby Promoting Viral Propagation. Abe T; Marutani Y; Deng L; Matsui C; Fukasawa M; Suzuki R; Wakita T; Matsuura Y; Shoji I J Virol; 2023 Jun; 97(6):e0065523. PubMed ID: 37272842 [TBL] [Abstract][Full Text] [Related]
12. Tree shrew bone marrow-derived mesenchymal stem cells express CD81, OCLN, and miR-122, facilitating the entire hepatitis C virus life cycle. Lu C; Feng Y; Sun X; Li N; Kuang D; Wang W; Tong P; Han Y; Xia X; Dai J J Med Virol; 2020 Dec; 92(12):3465-3474. PubMed ID: 32056224 [TBL] [Abstract][Full Text] [Related]
13. Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro. Fénéant L; Ghosn J; Fouquet B; Helle F; Belouzard S; Vausselin T; Séron K; Delfraissy JF; Dubuisson J; Misrahi M; Cocquerel L PLoS One; 2015; 10(11):e0142539. PubMed ID: 26561856 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition. Li Q; Sodroski C; Lowey B; Schweitzer CJ; Cha H; Zhang F; Liang TJ Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7620-5. PubMed ID: 27298373 [TBL] [Abstract][Full Text] [Related]
15. MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA. Sendi H; Mehrab-Mohseni M; Foureau DM; Ghosh S; Walling TL; Steuerwald N; Zamor PJ; Kaplan KJ; Jacobs C; Ahrens WA; Russo MW; Clemens MG; Schrum LW; Bonkovsky HL Liver Int; 2015 Apr; 35(4):1315-23. PubMed ID: 25302477 [TBL] [Abstract][Full Text] [Related]
16. Roles of epidermal growth factor receptor, claudin-1 and occludin in multi-step entry of hepatitis C virus into polarized hepatoma spheroids. So CW; Sourisseau M; Sarwar S; Evans MJ; Randall G PLoS Pathog; 2023 Dec; 19(12):e1011887. PubMed ID: 38157366 [TBL] [Abstract][Full Text] [Related]
17. Role of the cytosolic domain of occludin in trafficking and hepatitis C virus infection. Lavie M; Linna L; Moustafa RI; Belouzard S; Fukasawa M; Dubuisson J Traffic; 2019 Oct; 20(10):753-773. PubMed ID: 31328852 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C Virus Entry: Protein Interactions and Fusion Determinants Governing Productive Hepatocyte Invasion. Gerold G; Moeller R; Pietschmann T Cold Spring Harb Perspect Med; 2020 Feb; 10(2):. PubMed ID: 31427285 [TBL] [Abstract][Full Text] [Related]
19. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry. Riva L; Song OR; Prentoe J; Helle F; L'homme L; Gattolliat CH; Vandeputte A; Fénéant L; Belouzard S; Baumert TF; Asselah T; Bukh J; Brodin P; Cocquerel L; Rouillé Y; Dubuisson J J Virol; 2018 May; 92(10):. PubMed ID: 29491159 [TBL] [Abstract][Full Text] [Related]
20. Species-specific regions of occludin required by hepatitis C virus for cell entry. Michta ML; Hopcraft SE; Narbus CM; Kratovac Z; Israelow B; Sourisseau M; Evans MJ J Virol; 2010 Nov; 84(22):11696-708. PubMed ID: 20844048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]